Krishna Yeshwant
Overview
Krishna helps steward the GV investing team and co-leads GV’s life sciences group. As an investor, he is interested in the entire healthcare spectrum, including care delivery, health IT, devices, diagnostics, payor/provider, and therapeutics. Krishna led GV’s early investments in Adimab, Foundation Medicine, Editas Medicine, Beam Therapeutics, One Medical, and Aledade.
Portfolio Companies
Get the full list of 54,000+ investors
Krishna Yeshwant and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Krishna Yeshwant
What sectors does Krishna Yeshwant invest in?
Krishna Yeshwant invests in BioTech, Consumer Health, Cybersecurity, Social Networks, Enterprise and Consumer, and is based in Boston, Massachusetts. Krishna Yeshwant is listed as a investor in the ConnectSafely investor database.
What stage does Krishna Yeshwant invest at?
Krishna Yeshwant backs companies at Seed, Series A and Series B, writing cheques of $500K - $1M.
Which regions does Krishna Yeshwant invest in?
Krishna Yeshwant invests across US/Canada and Europe.
What companies has Krishna Yeshwant invested in?
Krishna Yeshwant's portfolio includes Insitro, Vera Therapeutics, Verve Therapeutics, Fractyl Laboratories, ROME Therapeutics, Verana Health, Quartet Health and Relay Therapeutics.
How do I contact Krishna Yeshwant?
Krishna Yeshwant's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database